These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Persisting decline in depression treatment after FDA warnings. Libby AM, Orton HD, Valuck RJ. Arch Gen Psychiatry; 2009 Jun; 66(6):633-9. PubMed ID: 19487628 [Abstract] [Full Text] [Related]
9. Impact of class-level labelling change on prescriptions of antidepressants for adolescents: An interrupted time-series study using a health insurance claims database in Japan, 2005-2013. Ogino Y, Schmidt AJ. PLoS One; 2020 Jun; 15(12):e0243424. PubMed ID: 33284822 [Abstract] [Full Text] [Related]
11. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. Am J Psychiatry; 2006 Nov; 163(11):1898-904. PubMed ID: 17074941 [Abstract] [Full Text] [Related]
18. Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis. Valiyeva E, Herrmann N, Rochon PA, Gill SS, Anderson GM. CMAJ; 2008 Aug 26; 179(5):438-46. PubMed ID: 18725616 [Abstract] [Full Text] [Related]
19. Antidepressants use in pediatric populations. Gören JL. Expert Opin Drug Saf; 2008 May 26; 7(3):223-5. PubMed ID: 18462180 [Abstract] [Full Text] [Related]
20. Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN). Wijlaars LP, Nazareth I, Petersen I. PLoS One; 2012 May 26; 7(3):e33181. PubMed ID: 22427983 [Abstract] [Full Text] [Related] Page: [Next] [New Search]